Business Context and Reporting Period
Company: Aspen Aerogels, Inc. (NYSE: ASPN)
Filing Type: Form 8-K (Current Report)
Date of Report: February 18, 2021
Reporting Period: Fourth Quarter and Fiscal Year ended December 31, 2020
This filing announces the financial results for the fourth quarter and full fiscal year 2020 and discusses recent business developments. The detailed financial data and operational results are contained in the press release attached as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text serves as a cover document referencing a press release for specific data. Consequently, the filing text itself does not provide clear values for the following metrics:
- Revenue
- Net Profit/Loss
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Position
Investors must refer to Exhibit 99.1 (the attached press release) for these specific figures.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It indicates that such comparisons and business developments are discussed within the referenced press release (Exhibit 99.1).
Guidance, Outlook, and Risks
2021 Financial Outlook: The filing explicitly incorporates the "2021 Financial Outlook" section from the press release into Item 7.01 (Regulation FD Disclosure). Specific guidance numbers are not present in this text.
Forward-Looking Statements: The filing includes a reference to a forward-looking statement disclaimer located at the end of the press release.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K; they are presumed to be covered in the referenced press release or prior periodic filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q4 and FY2020 revenue, earnings, and cash flow figures.
- Verify the specific "2021 Financial Outlook" guidance numbers incorporated by reference.
- Confirm the details of "business developments" mentioned in the announcement.
- Read the forward-looking statement disclaimer in the press release to understand associated risks.